Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 11, 2000 - Issue 3
Submit an article Journal homepage
37
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Kamillosan® is a safe product of camomile for topical application: results of patch testing consecutive patients with contact dermatitis

E Rudzki Department of Dermatology, Warsaw School of Medicine, Warsaw, Poland
&
S Jałońska Department of Dermatology, Warsaw School of Medicine, Warsaw, Poland
Pages 161-163 | Published online: 12 Jul 2009

  • Hausen B, Busker E, Carle R, Uber das Sensibiliserungsver-mögen in Compositenarten. Planta Medica (1984) 3: 205-84.
  • Paulsen E, Andersen KD, Hausen BM, Compositae dermatitis in a Danish dermatology department in one year. Part I. Contact Dermatitis (1993) 29: 6-10.
  • Paulsen E, Andersen KD, Compositae dermatitis in a Danish dermatology department in one year. Part II. Contact Dermatitis (1993) 29: 195-201.
  • Hausen B, A 6-year experience with compositae mix. Am J Contact Dermatitis (1996) 7: 94-9.
  • Klaschka F, Spättyp Allergie: Kontaktreaktionen der Haut und Schleimhaut. In: Klaschka F, Malwald L, Patzelt-Wenczler R (eds) Wirkungsweise und Anwendungsformen der Kamille. Grosse Verlag: Berlin, 1987.
  • Jabl?o´nska S, Rudzki E, Kamillosan Konzentrat: ein nicht allergisierender Extrakt aus Kamillen. Z Haut-Geschlekr (1996) 71: 542-5.
  • Rudzki E, Rebandel P, Positive patch test with Kamillosanfi in a patient with hypersensitivity to camomile. Contact Dermatitis (1998) 38: 184.
  • Rudzki E, Zawisza E, Rapiejko M et al, Oral allergy syndrome with contact urticaria from cosmetic creams. Contact Dermatitis (1999) 40: 326.
  • Mitchell H, Rook A, Botanical dermatology. Greenyrds: Vancouver, 1979.
  • Klaschka F, Patzelt-Wenczler R, Das allergene Potential der Kamille von Type IV in Extrema. Allergologie (1988) 11: 100-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.